Medication info
Telbarod ODT 80 mg (Telmisartan)

Telbarod ODT 80 mg (Telmisartan)

Prescription medicationOrally disintegrating TabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
BC World Pharmaceutical Co., Ltd.
Appearance
White round orally disintegrating tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202500041 · Approved 2025.01.06 · Insurance code 653103830

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; take without water. Do not crush or divide this medicine. Essential hypertension Adults: Administer telmisartan 40 mg orally once daily. It may be taken with or without food. If needed, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4~8 weeks after starting treatment when the dose is increased. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. Reduction of cardiovascular risk Adults: It is recommended to administer 80 mg of this medicine orally once daily. It may be taken with or without food. The effect of reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
BC World Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
View approved original text

This drug helps control blood pressure in patients with essential hypertension and reduces the risk of cardiovascular disease. It is especially effective in reducing the risk of myocardial infarction, stroke, and death due to cardiovascular disease in patients over 55 years of age with high cardiovascular disease risk (evidence of coronary artery disease, peripheral artery disease, stroke, and end-organ damage due to diabetes) who have difficulty taking ACE inhibitors. Therefore, it is useful for maintaining cardiovascular health and preventing related complications in such patients.

How to take

Adult dose

This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve; take without water. Do not crush or divide this medicine. Essential hypertension Adults: Administer telmisartan 40 mg orally once daily. It may be taken with or without food. If needed, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4~8 weeks after starting treatment when the dose is increased. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. Reduction of cardiovascular risk Adults: It is recommended to administer 80 mg of this medicine orally once daily. It may be taken with or without food. The effect of reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This drug can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this drug. Patients with severely impaired liver function or bile excretion problems should avoid this drug. Patients with an allergy to this drug or its ingredients should also avoid taking it. Patients with a history of angioedema or diabetic patients with moderate to severe renal impairment should not take this drug in conjunction with certain other medications. Elderly patients, those with hyperkalemia, and patients with slightly impaired liver function should use this drug cautiously. Those with heart disease, gastrointestinal disease, or renovascular hypertension also require caution. Blood pressure, renal function, and potassium levels should be monitored regularly when taking this drug, and patients should consult a doctor immediately if any unusual symptoms occur. Be aware that blood pressure may drop too low or symptoms such as dizziness and fainting may occur. If severe allergic reactions or symptoms of angioedema occur, discontinue use immediately and seek treatment. This drug may have interactions when used with other antihypertensives, so it is essential to consult a doctor. Particular care should be taken when used with lithium, diuretics, potassium supplements, and non-steroidal anti-inflammatory drugs. It is recommended to stop taking this drug 24 hours before surgery. Caution should be exercised while driving or operating dangerous machinery as this drug may cause dizziness or fainting. Safety and efficacy have not been established for children, and it is not recommended for use in this population. In the case of overdose, symptoms such as hypotension, dizziness, and acute kidney failure can occur, requiring immediate emergency treatment. Store this drug out of reach of children and keep it sealed until use.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 115 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • vertigo
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • fatigue
  • hunger pangs
  • cold sweats
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • hypotension
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • increased creatine kinase
  • elevated serum myoglobin
  • increased myoglobin in urine
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • arrhythmia
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • appetite loss
  • edema
  • decreased libido
  • facial swelling
  • rash
  • hair loss
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • appetite loss
  • weakness
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it is best to store it at room temperature between 1 degrees and 30 degrees Celsius. This will help maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

White round orally disintegrating tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.